Benjamin Jolley, PharmD, pharmacist at Jolley’s Compounding Pharmacy in Salt Lake City, Utah, discussed the state of independent pharmacy.
As an advocate for community pharmacy practices across the US, Benjamin Jolley, PharmD, pharmacist at Jolley’s Compounding Pharmacy in Salt Lake City, Utah, is focused on furthering the profession and getting pharmacists what they need to provide valued care to their communities. Jolley sat down with Drug Topics to discuss his career journey as well as the issues facing pharmacy that he is working to correct and alleviate on a daily basis.
“Community pharmacy practice in general is really, really tough from a financial standpoint, [from] a business-owner perspective. But also, that translates into, for anyone who works in a chain retail site, the margins on prescriptions are not what they were 10 years ago, even for the largest pharmacies,” he said.
As many experts know, declining reimbursements and workforce burnout—among many other issues—are significantly impacting the fabric of the pharmacy profession. Jolley discussed these challenges and how congressional action is the only way to turn the page on this chapter of pharmacy’s history.
On the most recent episode of Over the Counter, Jolley sat down to discuss the pharmacy profession as a way of celebrating American Pharmacists Month in October. Listen to our discussion with Jolley and learn why he’s so passionate about getting his industry the recognition it deserves.
To read more from this series, visit our American Pharmacists Month resource center.
Don’t get left behind: Sign up today for our free Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips delivered straight to your inbox.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
2 Commerce Drive
Cranbury, NJ 08512